Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
9.32
+0.24 (2.60%)
Nov 21, 2024, 1:28 PM EST - Market open
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $197.40 million as of November 21, 2024. Its market cap has increased by 2.92% in one year.
Market Cap
197.40M
Enterprise Value
145.97M
1-Year Change
2.92%
Ranking
Category
Stock Price
$9.32
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $197.40M, a decrease of -31.77%. That is a compound annual growth rate of -3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 192.40M | -2.93% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tide | 207.33M |
| Lexeo Therapeutics | 205.01M |
| Inhibrx Biosciences | 204.91M |
| XBiotech | 202.41M |
| Solid Biosciences | 200.17M |
| Amarin Corporation | 196.78M |
| ADC Therapeutics | 195.80M |
| Acrivon Therapeutics | 195.54M |